Literature DB >> 31319264

Furocoumarins as multi-target agents in the treatment of cystic fibrosis.

Anna Carbone1, Alessandra Montalbano1, Virginia Spanò1, Ilaria Musante2, Luis J V Galietta3, Paola Barraja4.   

Abstract

Multi-target molecular entities, offer a path to progress both in understanding causes of disease and in defining effective small molecule treatments. Coumarin and its derivatives belong to an important group of natural compounds with diverse biological properties. They are found in vegetables and plants for which literature reports thousands of publications for the great variety of biological applications among which the photoprotective effects, thus being considered multi-targeting agents. Their furan condensed analogues constitute the family of furocoumarins, less represented in the literature, endowed with photosensitizing properties and often used for the treatment of skin diseases such as vitiligo and psoriasis. Despite the study of biological properties of linear and angular furocumarins dates back to ancient times, mainly as photosensitizers, these small molecules still represent an attractive scaffold for further development and applications in several therapeutic fields. The aim of the present review is to summarize the most promising chemical entities belonging to the class of furocumarins and coumarins, emerged in the last decades, and the methods used for their synthesis with a particular focus on main targets involved in the cystic fibrosis treatment.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CFTR modulators; Cystic fibrosis (CF); Furocoumarins; Multi-target agents

Year:  2019        PMID: 31319264     DOI: 10.1016/j.ejmech.2019.07.025

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Mechanistic Insights into the Ameliorating Effect of Melanogenesis of Psoralen Derivatives in B16F10 Melanoma Cells.

Authors:  Yeji Lee; Chang-Gu Hyun
Journal:  Molecules       Date:  2022-04-19       Impact factor: 4.927

2.  Anti-Inflammatory Effects of Psoralen Derivatives on RAW264.7 Cells via Regulation of the NF-κB and MAPK Signaling Pathways.

Authors:  Yeji Lee; Chang-Gu Hyun
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

3.  Design, Synthesis, Spectroscopic Characterisation and In Vitro Cytostatic Evaluation of Novel Bis(coumarin-1,2,3-triazolyl)benzenes and Hybrid Coumarin-1,2,3-triazolyl-aryl Derivatives.

Authors:  Kristina Pršir; Ema Horak; Marijeta Kralj; Lidija Uzelac; Sandra Liekens; Ivana Murković Steinberg; Svjetlana Krištafor
Journal:  Molecules       Date:  2022-01-19       Impact factor: 4.411

4.  Isolation of a Melanoblast Stimulator from Dimocarpus longan, Its Structural Modification, and Structure-Activity Relationships for Vitiligo.

Authors:  Jae-Won Song; Sunju Choi; Gayeong Kim; Hyang Bok Lee; P Sankara Rao; Jeonghyun Shin; Eun Ki Kim; Dong-Gyu Cho
Journal:  Molecules       Date:  2022-03-25       Impact factor: 4.411

Review 5.  Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects.

Authors:  Salman Ahmed; Haroon Khan; Michael Aschner; Hamed Mirzae; Esra Küpeli Akkol; Raffaele Capasso
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

6.  Lumacaftor and Matrine: Possible Therapeutic Combination to Counteract the Inflammatory Process in Cystic Fibrosis.

Authors:  Michela Pecoraro; Silvia Franceschelli; Maria Pascale
Journal:  Biomolecules       Date:  2021-03-13

7.  Development of a Multi-Target Strategy for the Treatment of Vitiligo via Machine Learning and Network Analysis Methods.

Authors:  Jiye Wang; Lin Luo; Qiong Ding; Zengrui Wu; Yayuan Peng; Jie Li; Xiaoqin Wang; Weihua Li; Guixia Liu; Bo Zhang; Yun Tang
Journal:  Front Pharmacol       Date:  2021-09-15       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.